Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #856

    Oh really? thanks. they had one submitted in August for RA also.

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #857

      Its the same

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #858

        ok. understood. I know at the time they said they would file another IND before the end of the year, i cant remember what that would be for, i wrongly thought he was referring to that

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #859

          That was the hexa- and duobody compounds. Slides 16 and 17.

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #860

            Mærkeligt nok synes jeg ikke han nævnte den Tv-combo i frontline cervical, som fremgik af R&D præsentationen?

            1 Reply Last reply
            0
            • G Offline
              G Offline
              GeorgeBest
              wrote on sidst redigeret af
              #861

              Næh. Omkring TV sagde han 2. og 3. linie.

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #862

                Jeg spør ham på q&a

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #863

                  indeed, it actually says on p16 IND & CTAs filed in Q4 for DR5/DR5... i am a bit slow this morning ;-(

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Parasitism
                    wrote on sidst redigeret af
                    #864

                    You need a cup of Cirkel kaffe

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #865

                      😉

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #866

                        Jeg noterede mig at han ikke var bekymret for effektiviteten i DR5/DR5. Sikkerheden var det vigtigste udestående. De ville starte et studie "very soon" og allerede senere i år ville vi få de første sikkerhedsdata.

                        1 Reply Last reply
                        0
                        • J Offline
                          J Offline
                          JohnW
                          wrote on sidst redigeret af
                          #867

                          Er dagens kursfald en reaktion på Jans præsentation i går?

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            polle1
                            wrote on sidst redigeret af
                            #868

                            Hvorfor skulle det være det, JohnW ?

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #869

                              Det samme for cd3xcd20. Måske sikkerhedsdata senere i år.

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #870

                                Link Preview Image
                                Norsk kræftselskab viser lovende data på Genmab-område

                                Norske Bergenbio, der ligesom danske Genmab udvikler et lægemiddel rettet mod proteinet AXL, har vist positive effektdata for sin kandidat inden for behandling af lungekræft i kombination med et ældre lægemiddel fra Roche.

                                favicon

                                (medwatch.dk)

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #871

                                  Det kunne måske være fordi han overhovedet ikke kom ind på dara-salget i 18. Han nævnte kun at det for 17 forventes at lande i øvre ende af estimatet.

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raffles
                                    wrote on sidst redigeret af
                                    #872

                                    Vedr. JNJ-63723283 phase I study. Actual study start var Nov 2017 og Estimated Primary Completion date er March 2018. Der er 386 patienter! Det er da en ekstrem hurtig indrullering (NCT 03357952). Kan det virkelig lade sig gøre ??

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #873

                                      JP Morgan er en af de steder, hvor biotek indimellem ynder at smide en nyhed - det kom der ikke rigtig fra Genmab, så måske en lille skuffelse i markedet efter den flotte stigning

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #874

                                        Bears have pulled this same trick for 3months now; after ANY event, specially overnight which nobody has seen yet, just dump a few thousand shares in the morning and the negative tone is set...

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          GeorgeBest
                                          wrote on sidst redigeret af
                                          #875

                                          Deutsche Bank ude med research i dag: "Darzalex consensus expectations leave little room for upside" Anbefaling er hold med målpris på 1250

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger